Send a Tweet
Most Popular Choices
Share on Facebook Share on Twitter Printer Friendly Page More Sharing
General News    H3'ed 12/19/15

Former drug executive Martin Shkreli calls fraud allegations "baseless"

Quicklink Submitted By   2 comments
Become a Premium Member Would you like to know how many people have read this article? Or how reputable the author is? Simply sign up for a Advocate premium membership and you'll automatically see this data on every article. Plus a lot more, too.
Follow Me on Twitter     Message Sheila Samples
Become a Fan
  (49 fans)
Martin Shkreli
Martin Shkreli
(Image by Philip DeFranco, Channel: sxephil)
  Details   DMCA

Martin Shkreli, who is charged with securities fraud and conspiracy, having been arrested on Thursday, used Twitter on Saturday to say: “I am confident I will prevail. The allegations against me are baseless and without merit.” The 32-year-old former hedge fund manager pleaded not guilty on Thursday in Brooklyn federal court and was released on $5m bail. After he was released, he tweeted: “Glad to be home. Thanks for the support.” On Friday, he resigned from his company, Turing Pharmaceuticals. Prosecutors say that from 2009 to 2014, Shkreli lost some of his hedge fund investors’ money through bad trades, then looted a pharmaceutical company where he was chief executive for $11m to pay back his disgruntled clients.
Read the rest of the story HERE:

At www.theguardian.com

 

Rate It | View Ratings

Sheila Samples Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Sheila Samples is an Oklahoma writer and a former civilian US Army Public Information Officer. She is a Managing Editor for OpEd News, and a regular contributor for a variety of Internet sites.

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Follow Me on Twitter     Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: